# Oral Nitrite in Adults With Metabolic Syndrome and Hypertension

> **NCT01681810** · PHASE2 · COMPLETED · sponsor: **Gladwin, Mark, MD** · enrollment: 20 (actual)

## Conditions studied

- Metabolic Syndrome
- Hypertension

## Interventions

- **DRUG:** 14Nitrogen Sodium Nitrite

## Key facts

- **NCT ID:** NCT01681810
- **Lead sponsor:** Gladwin, Mark, MD
- **Sponsor class:** INDIV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2018-02-08
- **Final completion:** 2018-03-08
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2019-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01681810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01681810, "Oral Nitrite in Adults With Metabolic Syndrome and Hypertension". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01681810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*